[Federal Register Volume 84, Number 185 (Tuesday, September 24, 2019)]
[Notices]
[Pages 50077-50078]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20612]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on October 17, 2019, to discuss the draft report of 
the ACMUI

[[Page 50078]]

Training and Experience Subcommittee. This report will include the 
subcommittee's comments and recommendations on its review of the NRC 
staff's evaluation of the training and experience requirements for 
radiopharmaceuticals under title 10 Code of Federal Regulations (10 
CFR) 35.300, ``Use of unsealed byproduct material for which a written 
directive is required.'' Meeting information, including a copy of the 
agenda and handouts, will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html on or about October 2, 
2019. The agenda and handouts may also be obtained by contacting Ms. 
Kellee Jamerson using the information below.

DATES: The teleconference meeting will be held on Thursday, October 17, 
2019, 2:00 p.m. to 4:00 p.m. Eastern Time.

FOR FURTHER INFORMATION CONTACT: Any member of the public who wishes to 
participate in the teleconference meeting should contact Ms. Jamerson 
using the contact information below: Kellee Jamerson, email: 
[email protected], telephone: (301) 415-7408.

SUPPLEMENTARY INFORMATION: 

Conduct of the Meeting

    Dr. Darlene Metter, ACMUI Chairman, will preside over the meeting. 
Dr. Metter will conduct the meeting in a manner that will facilitate 
the orderly conduct of business. The following procedures apply to 
public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson at the contact information listed 
above. All submittals must be received by October 11, 2019, three 
business days prior to the October 17, 2019, meeting and must pertain 
to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2019.html on or about December 2, 2019.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.

    Dated: September 19, 2019.
Russell E. Chazell,
Federal Advisory Committee Management Officer.

    Subject: Federal Register Notice: Advisory Committee on the Medical 
Uses of Isotopes Meeting Notice. Dated September 19, 2019.

                                                ADAMS ML19261C009
----------------------------------------------------------------------------------------------------------------
              OFC                     MSST/MSEB           MSST/MSEB          MSST/MSEB              SECY
----------------------------------------------------------------------------------------------------------------
NAME...........................  KJamerson.........  LDimmick *........  CEinberg *.......  RChazell.
DATE...........................  9/18/2019.........  9/18/2019.........  9/18/2019........  9/ /2019.
----------------------------------------------------------------------------------------------------------------
*via email.

Official Record Copy

[FR Doc. 2019-20612 Filed 9-23-19; 8:45 am]
BILLING CODE 7590-01-P